Anemia

Iron deficiency anemia in an urban slum.
OBJECTIVE: Of this pilot study was to assess the iron status and dietary intake of 1-3 year-old apparently healthy toddlers of the lower socio-economic class, and the effect of eight weeks intervention with liquid oral iron in an urban slum in Pune, India.

Pune, India
India
Outcome of anaemic monochorionic single survivors following early intrauterine rescue transfusion in
OBJECTIVE: To evaluate the outcome of severely anaemic monochorionic (MC) twins surviving the death of their co-twin following early intrauterine rescue transfusion in cases of feto-fetal transfusion syndrome (FFTS).

Poissy, France
France
Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy
This study compared the effects of early intervention with standard use of epoetin alfa on haemoglobin (Hb) levels and transfusion requirements in cancer patients receiving chemotherapy.
Haaksbergerstraat 55
Enschede, The Netherlands 7513
The Netherlands
Erythropoietic agents for anemia of critical illness.
PURPOSE: Evidence regarding the cost-effective use of and benefits associated with epoetin alfa in treating anemia of critically ill patients is assessed.

Pittsburgh, PA
USA
Rituximab in the treatment of autoimmune haematological disorders.
Current treatment regimens for haematological autoimmune diseases are relatively non-selective and are often associated with considerable toxicity.

Toronto, Ontario
Canada
Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia
Purpose. To discuss the clinical issues we addressed in the development of our institutional guidelines regarding the assessment of iron stores for cancer- and treatment-related anemia and the administration of parenteral iron with erythropoiesis-stimulating agents (ESAs).

Chicago, Illinois
USA
Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving a
PURPOSE: The Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study evaluated whether epoetin beta would improve survival in patients with metastatic breast cancer (MBC).
Clinique de Genolier, 1 route du Muids
Genolier, Switzerland
Switzerland
Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia.
For children with severe aplastic anemia (SAA) who fail immunosuppressive therapy and lack a human leucocyte antigen (HLA)-matched sibling donor, unrelated donors provide a source of hematopoietic stem cells.

Washington, DC
USA
Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemia
Background: Patients with cancer may receive erythropoiesis-stimulating agents (ESAs), including darbepoetin alfa (DA) or epoetin alfa (EA), to treat cancer-related anemia (CRA). DA and EA differ, however, with respect to their assumed duration of effect and thus their approved frequency of dosing, complicating direct comparison of their doses and costs. Objective: The objective of this study was to examine, from the perspective of a third-party payer, patterns of use and costs of DA and EA in p

Brookline, Massachusetts
USA
Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and t
We retrospectively studied 49 patients in a single institute to evaluate the long-term outcome of total lymphoid irradiation (TLI) conditioning for allogeneic stem cell transplantation (allo-SCT) to treat aplastic anemia (AA).

Nagoya, Japan
Japan